Guidelines require all travellers (irrespective of COVID-19 vaccination status) coming to India from countries identified as ‘countries at-risk’ to mandatorily undergo post-arrival COVID-19 testing at airport on arrival.
The Serum Institute of India (SII) had put in an application to the Drugs Controller General of India (DCGI) in October for grant of market authorisation of Covovax for restricted use in emergency situations.
The health secretary said it is essential that the disease surveillance network in the country is geared up for rigorous follow-up of international travellers from all countries, especially those designated as 'at risk'.
The latest variant is the most heavily mutated version discovered so far. First identified in South Africa at the start of this week, the strain has already spread to neighbouring countries, including Botswana, where it has been reportedly detected in fully vaccinated people.
Maria van Kerkhove, WHO technical lead on COVID-19, said that in the year-end holiday period it was important for everyone to take protection measures against COVID-19, including vaccination and social distancing.
Many EU countries have already begun giving booster doses to their populations but are using different criteria to select groups that are prioritised and using different intervals between primary vaccinations and boosters.
The processes and incentives for these ambassadors, include assigning referral codes on Co-WIN for each one of them.Through these codes every person they get vaccinated will be added to their tally at COVID-19 Vaccination Centres (CVCs) through Co-WIN, the letter said.